ABBOTT LABORATORIES Other Non-Current Assets
ABBOTT LABORATORIES (ABT) had Other Non-Current Assets of $2.52 billion as of 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2016-11-03
- 2016-09-30: Other Assets, Noncurrent $2.52B.
- 2016-06-30: Other Assets, Noncurrent $2.61B.
- 2016-03-31: Other Assets, Noncurrent $2.61B.
- 2015-12-31: Other Assets, Noncurrent $2.12B.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2016-09-30 | $2.52B 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $2.61B 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $2.61B 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $2.12B 10-Q · filed 2016-11-03 | |
| 2015-09-30 | $1.38B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.33B 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $1.33B 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $3.29B 10-K · filed 2016-02-19 | $1.65B 10-K · filed 2015-02-27 |
| 2014-09-30 | $1.77B 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $1.92B 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $2.21B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $2.11B 10-K · filed 2015-02-27 | |
| 2013-09-30 | $2.67B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $2.08B 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $2.10B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $3.21B 10-K · filed 2014-02-21 | $3.21B 10-K · filed 2013-02-15 |
| 2012-09-30 | $2.98B 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $3.04B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $2.79B 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $2.56B 10-K · filed 2013-02-15 | |
| 2011-09-30 | $1.14B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $795.16M 10-Q · filed 2011-08-04 | |
| 2011-03-31 | $699.09M 10-Q · filed 2011-05-06 | |
| 2010-12-31 | $1.90B 10-K · filed 2013-02-15 | $790.03M 10-K · filed 2011-02-18 |
| 2010-09-30 | $1.28B 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $854.75M 10-Q · filed 2010-08-05 | |
| 2010-03-31 | $816.29M 10-Q · filed 2010-05-04 | |
| 2009-12-31 | $1.02B 10-K · filed 2012-02-21 | $858.21M 10-K · filed 2010-02-19 |
| 2009-09-30 | $1.35B 10-Q · filed 2009-11-06 | |
| 2009-06-30 | $1.29B 10-Q · filed 2009-08-07 | |
| 2008-12-31 | $1.95B 10-K · filed 2011-02-18 | |
| 2007-12-31 | $1.18B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |